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Preterm gut microbiota and 
metabolome following discharge 
from intensive care
Christopher J. Stewart1, Tom Skeath2, Andrew Nelson1, Sara J. Fernstad3, Emma C. L.  
Marrs4, John D. Perry4, Stephen P. Cummings1, Janet E. Berrington2 & 
Nicholas D. Embleton2
The development of the preterm gut microbiome is important for immediate and longer-term 
health following birth. We aimed to determine if modifications to the preterm gut on the neonatal 
intensive care unit (NICU) impacted the gut microbiota and metabolome long-term. Stool samples 
were collected from 29 infants ages 1–3 years post discharge (PD) from a single NICU. Additional 
NICU samples were included from 14/29 infants. Being diagnosed with disease or receiving increased 
antibiotics while on the NICU did not significantly impact the microbiome PD. Significant decreases 
in common NICU organisms including K. oxytoca and E. faecalis and increases in common adult 
organisms including Akkermansia sp., Blautia sp., and Bacteroides sp. and significantly different 
Shannon diversity was shown between NICU and PD samples. The metabolome increased 
in complexity, but while PD samples had unique bacterial profiles we observed comparable 
metabolomic profiles. The preterm gut microbiome is able to develop complexity comparable 
to healthy term infants despite limited environmental exposures, high levels of antibiotic 
administration, and of the presence of serious disease. Further work is needed to establish the direct 
effect of weaning as a key event in promoting future gut health.
The preterm gut microbiome has important influences in both the health and disease of neonates1. As a 
result the focus of previous work has been on the role of the bacterial community on the development of 
necrotising enterocolitis (NEC) and late onset sepsis (LOS)2–6. While such studies conflict in their find-
ings relating to disease pathogenesis, overall the bacterial diversity in the preterm gut increases over time 
with a reduction in initial facultative anaerobes including Staphylococcus and Enterococcus and increases 
in strict anaerobes including Bifidobacterium and Bacteroides7,8. Notably, this increase in strict anaerobes 
is significantly less than full term, vaginally delivered, breast fed infants over the first 90 days of life9.
The gut microbiome of term infants changes during the first year of life, resulting in an ‘adult-like’ 
profile between 1–4 years10–12. Bifidobacterium is the genus most differentially represented between child-
hood and adult profiles11. Previous studies suggest that clinical management in early life, such as anti-
biotic administration, may have profound long terms effects aside from direct gut health, increasing the 
risk of asthma13,14, allergy15, inflammatory bowel disease16,17, and obesity18,19 in childhood and adulthood. 
However, there is only limited evidence that links such conditions to modulations in early gut microbi-
ome development20–22.
A major knowledge gap remains regarding the functional metabolic consequences in the develop-
ment of the gut microbiome in preterm infants, especially following discharge from the NICU. This may 
have important consequences for clinical practise within NICUs, long term health, and offer potential 
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interventions that modulate health following discharge. The aim of this study was to explore changes in 
gut microbiota pre- and post-discharge from the NICU, their relationship to stool metabolomic profiles 
and any long-term impacts of key neonatal morbidities in preterm infants such as NEC and LOS.
Results
Bacterial profiling of the gut microbiota through the NICU and post discharge. PD stool sam-
ples from 29 infants aged 1–3 years were analysed as well as the first and last NICU stool samples from 
14 of the 29 patients. The PD gut microbiota of infants previously diagnosed with NEC and/or LOS was 
not significantly different compared to controls (P = <0.596). Nor was total days of antibiotic exposure, 
birth mode (caesarean section or vaginal), gestational age (< or> 27 weeks), or age of infant at PD sample 
collection (stratified as either 12–24 or 25–48 month). Thus, we focus our analysis on the development 
of the preterm gut microbiome through time.
Maximum parsimony based on the Bray-Curtis showed PD samples were significantly different from 
EN samples (P = 0.001) and LN samples (P = 0.001). Within the NICU samples there was also a signif-
icant difference (P = 0.002) between the EN and LN samples. These significant differences are observed 
in unconstrained PCA, where the NICU samples are relatively conserved compared to the PD sam-
ples, which show a much greater variability in the bacterial profiles (Fig. 1; for only NICU samples see 
Supplementary Figure S1). The most significant shifts in OTUs from EN to LN included a decreased rel-
ative abundance of S. aureus (P = <0.001) and increased relative abundance of Veillonella sp. (P = 0.045). 
Between the LN sample and the PD samples the most significant changes in OTU abundance were 
decreases in K. oxytoca (P =  >0.001), S. aureus (P = >0.001), E. faecalis (P = >0.001) and increases in 
Akkermansia sp. (P = >0.001), Blautia sp. (P = >0.001), Bacteroides sp. (P = >0.001), and Collinsella sp. 
(P = 0.002) (Fig. 2A; for individual profiles see Supplementary Figure S2).
A significant increase in the Shannon Diversity index (H′) of PD samples compared with EN 
(P = <0.001) and LN (P = <0.001) and between the two NICU time points (P = 0.02) was also observed 
(Fig. 2B). Phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) 
was implemented to predict functional content of the bacterial OTUs23. This showed that despite greater 
variation in of the bacterial community, the functional profiles of the PD samples had greater conserved 
functionality compared to the NICU samples (Fig. 3).
A novel visual inspection analysis of the bacterial profiles supports the above. Visual analysis of EN 
and LN groups confirmed a decrease of S. aureus in LN samples, as well as an increase of Veillonella sp 
(Supplementary Figure S3). The plot also indicates that there may be a decrease of K. oxytoca in LN sam-
ples although this was not significant in the statistical analysis. Visual analysis of the LN and PD samples 
showed PD samples are generally more diverse with higher levels in more OTUs (Supplementary Figure 
S4). However, A decrease in K. oxytoca, S. aureus and E. faecalis occurred from LN to PD, as well as 
Clostridium sensu stricto, although this was not significant in the main statistical analysis. As confirmed 
by the statistical analysis Akkermansia sp, Blautia sp, Bacteoides sp and Collinsella sp (are all increased in 
PD samples. However, these represent overall trends and not all samples followed this pattern.
Metabolomic profiling of the preterm gut through the NICU and post discharge. PLS-DA of 
metabolomic profiling data showed the grouping by time point to be highly predictive (EN R2VY = 0.85 
and Q2VY = 0.73, LN R2VY = 0.84 and Q2VY = 0.67, and PD R2VY = 0.96 and Q2VY = 0.93, where 
< 0.5 represents well modelled reproducible variables) (Fig. 4). Following removal of noise (metabolites 
Figure 1. Bacterial profiling PCA of all samples. Coloured according to time point. EN-LN P = 0.002; 
EN-PD P = 0.001; LN-PD P = 0.001.
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clustered around the origin and not associated with a given group), the metabolite profiles cluster almost 
exclusively based on time point, with the exception of EN samples from patients 139 and 172 which 
group with the LN samples (Fig. 5). However, analysis of only PD samples supervised according to NICU 
demographics including birth mode, gestational age, age at sample collection, days of antibiotics, or diag-
nosis of NEC and/or LOS did not show robustly modelled variables and were thus deemed not significant 
(e.g. Supplementary Figure S5), in accordance with the next generation sequencing data.
With the threshold used in SIEVE, 51,058 components (metabolites) were detected in total with the 
majority (47,631) being detected in all samples, regardless of time point (Supplementary Figure S6a). 
However, a general trend showed the lowest overall intensity in the EN samples and the highest intensity 
in PD samples. Although relatively low numbers of metabolites were shown to be specific to each group, 
there were 1,492 components only present in the LN and PD groups and a further 473 components only 
present in the PD group (Supplementary Figure S6b). No accurate and robust identification of significant 
metabolites associated with each time point could be determined.
Figure 2. Bacterial community and diversity across the three sample points. (A) Bar Chart showing 
the average bacterial profile at each time point (individual profiles in Supplementary Figure S2). Legend 
restricted to most abundant OTUs. (B) Box plot analysis of the Shannon Diversity index (H′) at each time 
point. EN-Early NICU, LN-Late NICU, PD-Post Discharge.
Figure 3. Area chart showing PICRUSt analysis of sequence data. Inferred metagenomic analysis using 
the data from the next generation sequencing to determine relative abundances of KEGG pathways encoded 
in the gut microbiota.
www.nature.com/scientificreports/
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Discussion
The aim of this study was to explore a crucial knowledge gap in the longitudinal development of the 
preterm gut microbiome following discharge from the NICU. We utilised two complementary technolo-
gies in bacterial 16S sequencing and metabolomics to more completely characterise microbiome changes. 
Because of the long timeframe needed to accrue sufficient numbers of very preterm infants surviving 
NEC or LOS, the PD samples in this study came from infants with ages ranging from 1–3 years, but all 
were consuming normal solid diets. We explored potential differences between the PD samples stratified 
by age and detected no significant difference and thus analysed them collectively.
A significant reduction in the relative abundance of S. aureus (P = <0.001) and an increased relative 
abundance of Veillonella sp. (P = 0.045) was found between the EN and LN periods. In accordance with 
previous studies, the highest levels of S. aureus in EN was found in patients delivered by caesarean 
section, with bacterial signatures of delivery mode lost in the LN samples prior to discharge24. While 
the bacterial diversity remained relatively low during NICU stay, there was a significant increase in 
diversity from EN to LN (P = 0.02), indicating the establishment of more complex gut communities in 
the NICU, despite restricted exposure to microorganisms8. It has previously been suggested that preterm 
infants undergo delayed establishment of the gut microbiome with lower overall diversity over the first 3 
months of life25. However, the bacterial diversity was found to significantly increase following discharge 
(P = <0.001), with diversity scores comparable to those of full term infants20.
PCA analysis of the bacterial profiles showed that the NICU samples cluster together independent of 
time point, however the PD samples show a high degree of variation. It is noteworthy that significant 
Figure 4. PLS-DA score scatter plot of Metabolomics raw data (R2Y = 89%). PLS-DA loadings-EN R2 
0.85, Q2 0.73; LN R2 0.84, Q2 0.67; PD R2 0.96 and Q2 0.93.
Figure 5. Metabolomics heatmap of all samples. All values were log10 transformed.
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changes between the relative abundance of species occurring during the NICU period are comparably 
minor compared to the much great complexity and individual nature of an infant gut microbiota fol-
lowing discharge. The most significant decreases in relative abundance PD corresponded to K. oxytoca 
(P = >0.001), S. aureus (P = >0.001), and E. faecalis (P = >0.001), which are organisms typically asso-
ciated with the NICU environment6,26. The significant reduction in these organisms probably represents 
increased exposure to non-hospital environmental microbes and a more complex diet10. The most sig-
nificant increases in relative abundance in PD samples corresponded to Akkermansia sp. (P = >0.001), 
Blautia sp. (P = >0.001), Bacteroides sp. (P = >0.001), and Collinsella sp. (P = 0.002). Importantly, these 
genus are all common constituents of the healthy adult gut microbiota and their presence further sug-
gests that the potentially vulnerable preterm gut is able to achieve a flora comparable to that of a healthy 
full term infant11. The reduction of previously abundant NICU organisms and increases in organism 
more common to the healthy adults gut microbiota is interesting and might represent the influence of 
more complex diet. For example, members of the genus Bacteroides are capable of utilising plant derived 
polysaccharides and by the PD stage of life in this study infants will be consuming complex solid diets27. 
Furthermore, Blautia was recently only detected following weaning in a piglet model28.
In contrast to the bacterial data, the metabolomic profiles showed a relatively high degree of compara-
bility between the PD samples. The majority of metabolites were detected at each time point, suggesting 
functional aspects of preterm gut microbiome development is uniform, as oppose to undergoing signifi-
cant stepwise changes after discharge. An increase in the number and intensity of identified metabolites 
correlated with increased life stages25. This is similar to data using gas chromatography MS (GCMS), 
where the number of detected volatile organic compounds (VOCs) were shown to increase with increas-
ing age in a comparable cohort of infants29.
The gradual progression of the gut metabolome corresponds with the microbiota data presented here 
and in previous studies, where the bacterial richness increased overtime, rather than new species replac-
ing existing species4. The striking observation of PD samples to have conserved metabolic function pro-
files, both for specific inferred bacterial function (PICRUSt analysis) and overall gut function (LCMS 
analysis), despite distinct and variable gut microbiota profiles, is important. This is in accordance with 
previous studies using metagenomic analysis which show un-weaned infants (i.e. not consuming com-
plex semi-solid foods) had a relatively simple gut microbiota, but high variation in functional compo-
sition in comparison to weaned infants and adults who had more a complex gut microbiota but greater 
functional uniformity, regardless of age or sex30,31. Such data suggests that the human gut requires a rela-
tively conserved suite of functions and the actual species colonizing the host and their relative abundance 
can vary, providing the individual has the overall functional capacity demonstrated here.
No significant long-term modifications to the gut microbiota were found in response to all patient var-
iables tested. The age of the infant at PD sampling did not have a significant effect on the gut microbiome, 
further suggesting the potential importance of sentinel events much earlier in infancy, such as weaning. 
We further show that diagnosis with serious disease (NEC and/or LOS) and the associated increased in 
antibiotic exposure did not have significant long-term effects on the gut microbiome. Further studies 
with larger numbers of infants are needed to describe how early alteration of the gut microbiome effects 
long-term inferences on the host, such as obesity19.
Although this study shows the preterm gut microbiome develops in a similar fashion to healthy full 
term infants, it is still unclear at which age an infant gut microbiome stabilises and remains comparable 
throughout adulthood. One emerging hypothesis is that the introduction of semi-solid foods is a key 
event where the gut microbiome develops into its adult form. Thus further work should focus sampling 
around and subsequently to these events as this crucial period may represent a ‘window of opportunity’ 
at which modification of the gut microbiota (eg with probiotics/prebiotics etc.) can influence long-term 
health32,33. Future follow-up work using carefully collected cohorts of preterm and term infants with 
detailed pheno- and entero-typing and demographic data throughout life presents the exciting possibility 
to explore how the early gut microbiome development influences growth, development, and health and 
disease throughout maturity.
In summary, we show that the preterm gut microbiome undergoes significant changes following dis-
charge from the NICU, with an increase in diversity and accumulation of organisms comparable to that 
of term infants, regardless of earlier disease and limited environmental exposure. Furthermore, while 
increased complexity and individualisation of the gut microbiota correlated with increased age, the over-
all functional properties of the gut metabolome become more stable and conserved between infants.
Methods
Ethics statement. Ethics approval was obtained from the County Durham and Tees Valley Research 
Ethics Committee and written informed parental consent was obtained. The methods were carried out 
in accordance with the approved guidelines.
Infants and samples. Infants who had enrolled to our SERVIS study were approached in a selective 
manner and asked to provide a stool sample in later infancy. Infants were selected on the basis of previ-
ous disease state (NEC and/or LOS) and gestationally matched controls. Fifty-five infants were identified 
based on all previous NEC (n = 20) and LOS (n = 15) cases and sufficient controls (n = 20). Of the 56, 
29 contributed a post discharge stool (8 NEC, 6 LOS, 3, NEC and LOS, and 12 controls) between 1 and 
www.nature.com/scientificreports/
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3 years of age (Table 1). Post discharge (PD) stool samples were sent using standard postal systems and 
stored at − 20 °C immediately upon receipt and then at − 80 °C.
Additional analysis was carried out on an early NICU (EN) and late NICU (LN) stool pre discharge 
from 14 infants (n = 28), where detailed sequencing data was available from patients involved in another 
study (MG-RAST accession numbers 4603816.3–4603844.3). 16S rRNA bacterial profiling was per-
formed on all samples in the study. Metabolomics was carried out on all samples, with the exception of 
the NICU samples from patients 173 and 188, where insufficient informative sample remained. The unit 
has standardised feeding practices, antibiotic and antifungal use and no infant was supplemented with 
probiotics during their NICU stay.
16S rRNA Bacterial profiling. Nucleic acid extraction of stool was carried out on 100 mg of sample 
using the PowerLyzer™ PowerSoil® DNA Isolation Kit (MoBio, CA, USA) in accordance with the man-
ufacturer’s instructions. Bacterial profiling utilised the 16S rRNA gene targeting variable region 4 (V4) 
and was carried out by NU-OMICS (Northumbria University) based on the Schloss wet-lab MiSeq SOP 
and raw fastq data were processed using Mothur (version 1.31.2) as previously described34. Chimeric 
sequences were detected by Chimera.uchime and removed from downstream analysis. Alignment was 
generated via the Silva database35. A cutoff of 70 was applied to assign sequences to the trainset9_032012 
resulting in 5,496,973 reads. All sequences from PD samples were deposited in MG-RAST under the 
accession numbers 4516545.3–4516585.3.
Patient Diagnosis1
Birth 
Weight
Gestation 
Age
Birth 
Mode
Breast 
Milk
First Breast 
Milk (DOL)
Full Feed 
72 hrs (DOL)
NICU Antibiotics 
(days)
Age at sampling
Day of 
EN2
Day of 
LN2
Month 
of PD
29 N S 800 25 V Y 3 34 16 – – 48
47 N S 760 26 V Y 3 15 43 – – 46
61 N 1030 27 V Y 2 14 20 – – 42
66 S 630 24 V Y 3 22 32 – – 41
71 S 860 26 V Y 11 21 12 – – 33
114 S 750 25 V Y 1 7 21 – – 32
117 C 870 26 CS Y 2 10 2 12 60 26
127 N 1600 31 V Y 1 19 24 – – 25
129 N S 700 24 V Y 3 35 31 – – 28
130 C 1000 27 CS Y 4 15 15 8 83 28
131 C 545 27 CS Y 4 27 7 10 54 23
138 N 804 26 CS Y 7 28 19 – – 27
139 N 1470 30 CS Y 2 10 6 8 42 26
146 N 1195 28 V Y 2 14 13 – – 23
151 C 1020 27 V Y 1 Missing 32 – – 25
154 N 1060 28 V Y 1 7 19 – – 25
172 S 1060 28 V Y 1 10 9 8 50 23
173 S 1150 28 CS Y 2 18 16 2 34 23
174 N 1350 29 CS N N/A 15 16 11 48 23
181 S 570 23 V Y 4 14 2 8 88 22
188 C 750 24 V Y 2 39 13 4 94 22
203 C 1130 26 V Y 1 15 5 2 68 20
206 C 1255 28 V Y 0 11 7 4 51 20
213 N 1120 28 CS N N/A 9 6 – – 20
222 C 620 24 V Y 3 21 15 5 86 19
224 C 1170 28 V Y 2 24 4 4 51 19
228 C 910 25 V Y 4 14 34 3 94 19
271 C 2030 31 V Y 2 8 2 – – 14
272 C 1535 31 V Y 2 7 2 – – 14
Table 1.  Patient demographics. 1N – Necrotising enterocolitis, S – late onset sepsis, C – control. 2represents 
no NICU sample was obtained from the patient.
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LCMS/MS metabolomic profiling. Water, methanol, and acetonitrile (ACN) were liquid chroma-
tography mass spectrometry (LCMS) grade (VWR). Metabolites were extracted from 100 mg stool, 
homogenised in 1 mL cold 80% methanol by vortexing for 15 min at 4 °C. The suspension was then 
centrifuged at 10,000 × g for 10 min at 4 °C and lyophilised in a freeze dryer before storage at − 80 °C. 
Samples were re-suspended in 1 mL of initial start phase buffer (5% ACN). Stool metabolite profiling was 
performed using reverse-phase ultra-performance LCMS tandem mass-spectrometry (UPLC-MS/MS). 
An Accucore C18 column (2.6 μ m, 150 × 2.1 mm) was used at 40 °C with a 3.0 μ l injection and 300 μ l/
min flow rate throughout. A multi-step LC gradient was used with 5% ACN increasing to 95% ACN 
over 22 minutes, with a further 95% ACN for 3 minutes followed by a final 5 minutes re-equilibration 
at 5% ACN. Samples were run in triplicate and the order of samples in each triplicate sequence was 
randomised. A blank consisting of LCMS grade water underwent the same procedure and an aliquot of 
every sample was used as a pool. Prior to each run a blank and 5 pools were processed to equilibrate 
the system and then blanks and pools were processed periodically every 10 samples. A Q-Exactive 
(Thermo) was used for the MS and subsequent data dependant MS/MS. Metabolomic profiling was 
performed using HESI with high resolution (70,000) positive and negative switching. The mass range 
was set from 100–1000 m/z. MS/MS was subsequently employed with data dependency based on the 
metabolites of interest.
SIEVE (Version 2.2 beta) was used to process the Thermo RAW files by component extraction. All 
blanks were used for background subtraction. Positive and negative data were processed individually 
and combined prior to downstream analysis. An intensity threshold of 500,000 was applied detecting 
a total of 51,058 components (36,405 positive and 14,653 negative). Data dependant MS/MS (ddMS2) 
analysis of significant components was performed for putative identification and monoisotopic masses 
were matched against inhouse standards, however accurate metabolite identification could not be 
obtained.
Statistical analysis. For normalisation of the NGS bacterial profiling data, all samples were sub-
sampled to 35,448 reads and singleton reads were removed. Significance of variables in the NGS data 
was analysed within Mothur using maximum parsimony based on the Bray-Curtis, where P-values of 
< 0.05 were deemed significant. Bacterial profiling data was analysed by principal component analysis 
(PCA) using SIMCA 13.0 (Umetrics, Stockholm, Sweden)36. Metabolomic profiling data was analysed 
using partial least squared-discriminatory analysis (PLS-DA). Operational taxonomic units (OTUs) and 
components were automatically log transformed within SIMCA. Only variables with a VIP of > 1 were 
included and the most significant variables associated with each group were determined based on the 
variables with error bars above 0 in the coefficient plot37. Multiple iterations of the VIP analysis were 
conducted for optimal noise reduction (Supplementary Figure S7). To check that data was adhering to 
multivariate normalities, Hotelling’s T2 tolerance limits were calculated and set at 0.95. Heatmaps were 
generated in R using the vegan and gplots packages.
The bacterial profiles of the samples were further visually investigated using a Parallel Coordinates 
plot38, where each axis represents an OTUs and the bacterial profile of a sample is represented by a 
polyline intersecting the axes at corresponding bacterial level. The sample profiles are coloured according 
to sample classification to support comparison between sample groups. The profiles are log transformed 
and display the 40 most abundant OTUs.
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